OKUR
OnKure Therapeutics, Inc. Class A Common Stock
OKUR
OKUR
38 hedge funds and large institutions have $137M invested in OnKure Therapeutics, Inc. Class A Common Stock in 2021 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 10 increasing their positions, 11 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
38
Holders Change
–
Holders Change %
0%
% of All Funds
0.67%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
4
Increased
10
Reduced
11
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
IC
Ikarian Capital
Dallas,
Texas
|
+$1.3M |
| 2 |
A
Abingworth
London,
United Kingdom
|
+$825K |
| 3 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$745K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$362K |
| 5 |
State Street
Boston,
Massachusetts
|
+$187K |
Top Sellers
| 1 |
NIP
Nicholas Investment Partners
Rancho Santa Fe,
California
|
-$2.11M |
| 2 |
PM
Prosight Management
Dallas,
Texas
|
-$513K |
| 3 |
Franklin Resources
San Mateo,
California
|
-$373K |
| 4 |
PCM
Pinz Capital Management
New York
|
-$281K |
| 5 |
Morgan Stanley
New York
|
-$195K |
